EditorialPATIENT ADVOCACY

Enhancing quality of life as a goal for anticancer therapeutics

Science Translational Medicine  22 Jun 2016:
Vol. 8, Issue 344, pp. 344ed9
DOI: 10.1126/scitranslmed.aag0382

You are currently viewing the abstract.

View Full Text

Abstract

Translational cancer research requires a quality-of-life–driven agenda.

View Full Text